128 results
Page 5 of 7
8-K
1van4hsy ux
24 Apr 20
Submission of Matters to a Vote of Security Holders
4:38pm
DEF 14A
h0fjqhpb4p
6 Apr 20
Definitive proxy
6:11am
PRE 14A
c7cyjw13szjtagi6jps
30 Mar 20
Preliminary proxy
5:03pm
10-K
EX-31.1
vz09guavaz1 gd
17 Mar 20
Annual report
5:27pm
10-K
EX-31.2
sapki3tm 0xnst
17 Mar 20
Annual report
5:27pm
10-K
3bdvuxv6rct
17 Mar 20
Annual report
5:27pm
8-K
tqvwnw0 57mf
16 Mar 20
Other Events
4:32pm
8-K
nyz9n3r2i4f0x3ff85sj
31 Jan 20
Other Events
5:01pm
6-K
EX-10.1
v0rv7g 9g
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm
S-8
EX-99.2
g3xxoo3aetch
22 Jul 19
Registration of securities for employees
5:17pm
6-K
fe0wblsogkessf
8 Jul 19
Current report (foreign)
7:30am
6-K
EX-99.1
4uesoebx
28 May 19
Notice of Annual General Meeting of Shareholders of the Company
5:26pm
6-K
EX-99.3
mi598ga
28 May 19
Notice of Annual General Meeting of Shareholders of the Company
5:26pm
6-K
EX-99.2
qdmvp8ls5dfvz
28 May 19
Notice of Annual General Meeting of Shareholders of the Company
5:26pm
20-F/A
glwvd7hfz
24 Apr 19
Annual report (foreign) (amended)
5:19pm
20-F/A
EX-12.1
xa6i4hg
24 Apr 19
Annual report (foreign) (amended)
5:19pm
20-F/A
EX-12.2
q7vcn vu43q883ndjxt
24 Apr 19
Annual report (foreign) (amended)
5:19pm